Afynia (formerly AIMA Laboratories) is a medical diagnostic company commercializing the first diagnostic blood test for endometriosis. It is estimated that 400 million women are diagnosed each year with chronic pelvic pain of which 50-65% will ultimately be diagnosed with endometriosis. Sadly, it takes between 5 and 12 years from onset of symptoms for a diagnosis. Afynia’s test detects endometriosis with the same accuracy as surgery and provides women and their doctors with actionable data to take back control of their lives.
Founders

Dr. Lauren Foster
Co-Founder

Dr. Jocelyn Wessels
Co-Founder
Featured Stories

Afynia Secures $5M to Fast-Track Groundbreaking Endometriosis Blood Test
Afynia Laboratories has picked up $5 million in seed funding to advance its blood test for endometriosis. This is the...

Former McMaster Researchers Announce $2 Million to Bring Endometriosis Test to Market
This article was first published by betakit. Read the original article Led by two former McMaster University research scientists with...